The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Mylan NV

Nasdaq: MYL
Last

(U.S.) $69.66

Today's change-0.28 -0.40%
Updated May 22 4:00 PM EDT. Delayed by at least 15 minutes.
 

Mylan NV

Nasdaq: MYL
Last

(U.S.) $69.66

Today's change-0.28 -0.40%
Updated May 22 4:00 PM EDT. Delayed by at least 15 minutes.

Mylan NV down (U.S.)$0.28

Mylan NV closed lower Friday, dropping (U.S.)$0.28 or 0.40% to (U.S.)$69.66. Shares have lost 1.43% over the last five days, but have gained 23.58% over the last year to date. This security has outperformed the S&P 500 by 34.59% during the last year.

Key company metrics

  • Open(U.S.) $70.00
  • Previous close(U.S.) $69.94
  • High(U.S.) $70.55
  • Low(U.S.) $69.49
  • Bid / Ask-- / --
  • YTD % change+23.58%
  • Volume4,333,753
  • Average volume (10-day)4,616,749
  • Average volume (1-month)8,075,244
  • Average volume (3-month)9,105,707
  • 52-week range(U.S.) $44.80 to (U.S.) $76.69
  • Beta1.18
  • Trailing P/E32.09×
  • P/E 1 year forward16.88×
  • Forward PEG1.39×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.17
Updated May 22 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+11.09%

Based on its net profit margin of 11.09%, Mylan NV is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.09%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue1,8722,0832,0841,837
Total other revenue--------
Total revenue1,8722,0832,0841,837
Gross profit8389821,024819
Total cost of revenue1,0341,1011,0601,019
Total operating expense1,7051,6971,5931,612
Selling / general / administrative413349379356
Research & development152150157139
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)107987797
Other operating expenses, total--0-80--
Operating income166385491226
Interest income (expense), net non-operating-84-50-92-93
Gain (loss) on sale of assets--------
Other--------
Income before tax61272413138
Income after tax57191499127
Income tax, total582-8711
Net income57189499125
Total adjustments to net income--------
Net income before extra. items57189499125
Minority interest0-10-1
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items57189499125
Inc. avail. to common incl. extra. items57189499125
Diluted net income57189499125
Dilution adjustment--0----
Diluted weighted average shares444401397397
Diluted EPS excluding extraordinary itemsvalue per share0.130.471.260.32
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share0.350.641.380.54